Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 59.21 - -
Change - -45.55% -68.19% 94.7% -47.16% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 59.21 59.21 59.21
Change - -45.55% -68.19% 94.7% -47.16% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 49.3x 45.5x 37x
EV / Revenue - 0x 0x 0x 49.3x 45.5x 37x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -9.11x -9.25x -
EV / FCF - -0x - -0x -9.25x -16.4x -15.2x
FCF Yield - -9.52% - -4.08% -10.8% -6.08% -6.59%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.7400 0.7400 0.7400
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 3/1/23 5/15/24 5/13/25 5/13/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 68.27M
109.14x6.07x25.76x2.28% 370B
23.56x3.19x11.13x1.68% 70.44B
14.95x7.32x11.22x - 12.23B
17.15x2.22x7.53x2.58% 8.79B
21.13x6.63x17.65x-.--% 5.08B
41.52x2.6x29.7x0.69% 4.5B
35.7x5.58x16.33x - 3.11B
-218.7x - - -.--% 2.54B
Average 5.56x 4.80x 17.05x 1.2% 52.94B
Weighted average by Cap. 88.57x 5.58x 22.76x 2.14%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. AB Stock
  4. Valuation AB Science